- Home
- SIF vs CLDI Comparison
SIF vs CLDI Comparison
Compare SIF & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- CLDI
- Stock Information
- Founded
- SIF 1913
- CLDI 2014
- Country
- SIF United States
- CLDI United States
- Employees
- SIF N/A
- CLDI N/A
- Industry
- SIF Office Equipment/Supplies/Services
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SIF Industrials
- CLDI Health Care
- Exchange
- SIF Nasdaq
- CLDI Nasdaq
- Market Cap
- SIF 18.6M
- CLDI 10.2M
- IPO Year
- SIF N/A
- CLDI N/A
- Fundamental
- Price
- SIF $4.04
- CLDI $0.25
- Analyst Decision
- SIF
- CLDI
- Analyst Count
- SIF 0
- CLDI 0
- Target Price
- SIF N/A
- CLDI N/A
- AVG Volume (30 Days)
- SIF 22.3K
- CLDI 1.6M
- Earning Date
- SIF 08-11-2025
- CLDI 08-12-2025
- Dividend Yield
- SIF N/A
- CLDI N/A
- EPS Growth
- SIF N/A
- CLDI N/A
- EPS
- SIF N/A
- CLDI N/A
- Revenue
- SIF $83,554,000.00
- CLDI N/A
- Revenue This Year
- SIF N/A
- CLDI N/A
- Revenue Next Year
- SIF N/A
- CLDI N/A
- P/E Ratio
- SIF N/A
- CLDI N/A
- Revenue Growth
- SIF 35.83
- CLDI N/A
- 52 Week Low
- SIF $2.33
- CLDI $0.20
- 52 Week High
- SIF $5.96
- CLDI $3.89
- Technical
- Relative Strength Index (RSI)
- SIF 72.21
- CLDI 30.55
- Support Level
- SIF $2.95
- CLDI $0.20
- Resistance Level
- SIF $4.25
- CLDI $0.25
- Average True Range (ATR)
- SIF 0.29
- CLDI 0.03
- MACD
- SIF 0.05
- CLDI -0.00
- Stochastic Oscillator
- SIF 99.92
- CLDI 28.48
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.